RKLB Price Prediction Next Week
Analysis and Insights
Technical Analysis:
Rocket Lab USA, Inc. (RKLB) is currently trading at $17.95 as of 2025-03-10. The stock is showing signs of being oversold, with RSI values of 32.03 (RSI_6), 33.13 (RSI_12), and 34.34 (RSI_14), all below the 50 threshold. The MACD is negative at -2.27, indicating bearish momentum. The stock is trading below its 20-day SMA of $23.63, which is a bearish signal.
News and Sentiment Analysis:
Rocket Lab recently reported strong Q4 2024 results, with revenue of $132.4 million, beating estimates. However, the company provided weaker-than-expected Q1 2025 guidance, which has weighed on the stock. Despite this, Rocket Lab announced a successful moon landing mission, which is a positive catalyst. ARK Invest's sale of 76,331 shares has also impacted the stock price, causing a 3% drop. Analysts maintain a Moderate Buy rating with a target price of $25.72.
Fibonacci Levels:
The Fibonacci levels for RKLB show resistance at $22.97 (R1) and $24.80 (R2), with support at $17.07 (S1) and $15.24 (S2). The pivot point is at $20.02.
Conclusion:
Based on the technical indicators and news sentiment, RKLB is likely to experience a short-term rebound. The stock is oversold, and the successful moon landing mission could act as a catalyst. The target price for the next trading week is $20.50, with a stop-loss at $17.50.
Recommendation: Buy RKLB with a target price of $20.50 and a stop-loss at $17.50.
RKLB Similar Chart Price Prediction
The price of RKLB is predicted to go up -0.01%, based on the high correlation periods with UBFO. The similarity of these two price pattern on the periods is 98.71%.
RKLB
UBFO
Down: -0.01%Similarity: 98.71%
RKLB Revenue Forecast
RKLB EPS Forecast
RKLB FAQs
What is RKLB revenue forecast for next quarter？
What is RKLB eps forecast for next quarter？
RKLB Analyst's Forecast
Kristine Liwag
Morgan Stanley
Hold
2025-03-10
Price Target
$18 → $20
Upside
+16.82%
Morgan Stanley raised the firm's price target on Rocket Lab to $20 from $18 and keeps an Equal Weight rating on the shares. After about a 360% run in 2024, the stock has underperformed the market by about 25% year-to-date in part on questions around the readiness of Neutron, Rocket Lab's new medium-lift class rocket program, the analyst tells investors. However, the second half of 2025 target for Neutron's debut reflects "a relatively modest delay," says the analyst, who raised the firm's target post-Q4 results.
Matthew Akers
Wells Fargo
Hold
2025-03-03
Price Target
$22 → $21
Upside
+12.54%
Jason Gursky
Citigroup
Strong Buy
2025-01-21
Price Target
$22 → $35
Upside
+11.93%
